D. E. Shaw & Co., Inc. Theseus Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$5.04 - $14.05 $52,476 - $146,288	10,412 New	10,412 $58,000
Q1 2022 May 16, 2022	SELL	$8.75 - $14.51 $193,690 - $321,193	-22,136 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.98 - $20.09 $198,781 - $444,712	22,136 New	22,136 $281,000

1.03M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.